GL1X · GenesisL1 explorer

Research workbench

Cisplatin lesion containing RNA polymerase II elongation complex

Analyse Cisplatin lesion containing RNA polymerase II elongation complex in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2R7Z
Type
protein + DNA + RNA
Length
3,947 residues
Chains
15
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
5'-D(*TP*AP*CP*TP*TP*GUP*CP*CP*CP*TP*CP*CP*TP*CP*AP*T)-3'; 5'-D(*CP*AP*AP*GP*TP*AP*G)-3'…
EC
2.7.7.6
UniProt
P04050, P08518, P16370, P20433, P20434, P20435, P34087, P20436, P27999, P22139, P38902, P40422
Ligands
CPT, ZN, MG
Pockets
20 · best druggability 0.88

Structure

x-ray diffraction · 15 distinct chains · 31% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
T5'-D(*TP*AP*CP*TP*TP*GUP*CP*CP*CP*TP*CP*CP*TP*CP*AP*T)-3'dna17——
N5'-D(*CP*AP*AP*GP*TP*AP*G)-3'dna7——
P5'-R(*UP*UP*UP*GP*AP*GP*GP*AP*GP*G)-3'rna10——
ADNA-directed RNA polymerase II subunit RPB1 (EC 2.7.7.6)protein141639% helix, 14% strandP04050
BDNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6)protein110828% helix, 19% strandP08518
CDNA-directed RNA polymerase II subunit RPB3 (EC 2.7.7.6)protein26623% helix, 20% strandP16370
DDNA-directed RNA polymerase II subunit RPB4 (EC 2.7.7.6)protein17747% helix, 6% strandP20433
EDNA-directed RNA polymerases I, II, and III subunit RPABC1 (EC 2.7.7.6)protein21435% helix, 20% strandP20434
FDNA-directed RNA polymerases I, II, and III subunit RPABC2 (EC 2.7.7.6)protein8430% helix, 15% strandP20435
GDNA-directed RNA polymerase II subunit RPB7 (EC 2.7.7.6)protein17110% helix, 49% strandP34087
HDNA-directed RNA polymerases I, II, and III subunit RPABC3 (EC 2.7.7.6)protein1332% helix, 41% strandP20436
IDNA-directed RNA polymerase II subunit RPB9 (EC 2.7.7.6)protein1190% helix, 23% strandP27999
JDNA-directed RNA polymerases I, II, and III subunit RPABC5 (EC 2.7.7.6)protein6548% helix, 0% strandP22139
KDNA-directed RNA polymerase II subunit RPB11 (EC 2.7.7.6)protein11436% helix, 24% strandP38902
LDNA-directed RNA polymerases I, II, and III subunit RPABC4 (EC 2.7.7.6)protein460% helix, 9% strandP40422

Ligands and binding sites

  • CPT · Cisplatin · ligand · chains T
  • ZN · Zinc ion · metal · 8 copies · chains A, B, C, I, J, L
  • MG · Magnesium ion · metal · chains P, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19240.880.90107empty
27710.870.9094empty
310830.840.85101empty
49280.830.8488empty
510560.820.83113empty

Interfaces

37 interfaces between chains.

  • A–B · 9782 Ų buried · 133 hydrogen bonds · protein-protein
  • D–G · 2349 Ų buried · 22 hydrogen bonds · protein-protein
  • A–E · 2230 Ų buried · 27 hydrogen bonds · protein-protein
  • C–K · 2135 Ų buried · 12 hydrogen bonds · protein-protein
  • A–F · 2108 Ų buried · 17 hydrogen bonds · protein-protein

Compared structures

  • 2R7Z · Cisplatin lesion containing RNA polymerase II elongation complex · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.